Valuation: Clover Corporation Limited

Market Cap 159M 112M 97.29M 90.55M 83.14M 157M 10.68B 1.07B 419M 5.32B 420M 411M 17.83B P/E 2026 *
16.4x
P/E 2027 * 11.9x
Enterprise Value 157M 110M 95.88M 89.25M 81.94M 155M 10.53B 1.05B 413M 5.24B 414M 405M 17.58B EV / Sales 2026 *
1.67x
EV / Sales 2027 * 1.31x
Free-Float
76.93%
Yield 2026 *
-
Yield 2027 * -
1 day+1.59%
1 week+9.09%
1 month+13.61%
3 months-1.54%
6 months+23.08%
Current year+21.52%
1 week 0.88
Extreme 0.88
0.96
1 month 0.7
Extreme 0.7
0.96
Current year 0.7
Extreme 0.7
1.16
1 year 0.52
Extreme 0.525
1.16
3 years 0.34
Extreme 0.337
1.16
5 years 0.34
Extreme 0.337
1.8
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 11/11/2014
Director of Finance/CFO - 06/05/2021
Chief Operating Officer - 03/02/2011
Director TitleAgeSince
Director/Board Member - 11/11/2014
Chairman - 21/09/2017
Director/Board Member - 01/02/2017
Date Insider Type Main position Quantity % Market Cap.
18/11/25 Sell

Chief Executive Officer

255,199 0.1528%
18/11/25 Buy

Chief Executive Officer

529,638 0.3171%
6/11/25 Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+1.59%+9.09%+72.97%-11.93% 112M
-1.67%+0.87%+33.97%+81.88% 13.64B
+5.61%+3.04%-29.51%+248.27% 7.84B
+2.86%+7.63%-11.30%-50.66% 2.59B
-5.78%-4.32%-77.30%-65.54% 1.44B
-0.16%+4.46%+35.00%-23.52% 1.29B
-.--%+7.03%-28.46%-25.88% 1.28B
+0.17%+1.17%+22.92%+36.11% 1.22B
+1.07%-5.12%-37.13% - 1.12B
-1.93%-0.39%-66.58%-73.70% 901M
Average +0.18%+2.09%-8.54%+12.78% 3.14B
Weighted average by Cap. +0.63%+1.82%+1.11%+90.75%

Financials

2026 *2027 *
Net sales 94M 65.98M 57.36M 53.39M 49.02M 92.57M 6.3B 629M 247M 3.14B 248M 242M 10.51B 116M 81.5M 70.84M 65.94M 60.54M 114M 7.78B 777M 305M 3.87B 306M 299M 12.99B
Net income 9.8M 6.88M 5.98M 5.57M 5.11M 9.65M 657M 65.61M 25.75M 327M 25.84M 25.27M 1.1B 13.5M 9.48M 8.24M 7.67M 7.04M 13.29M 905M 90.38M 35.47M 450M 35.59M 34.81M 1.51B
Net Debt -2.3M -1.61M -1.4M -1.31M -1.2M -2.26M -154M -15.4M -6.04M -76.73M -6.06M -5.93M -257M -7.2M -5.05M -4.39M -4.09M -3.75M -7.09M -482M -48.2M -18.92M -240M -18.98M -18.56M -805M
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
68
Date Price Change Volume
31/07/26 $0.9600 +1.59% 51,455
30/07/26 $0.9450 +2.16% 523,125
29/07/26 $0.9250 +1.09% 18,113
28/07/26 $0.9150 -2.14% 4,681
27/07/26 $0.9350 +6.25% 74,895
Trader
-
Investor
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.9600AUD
Average target price
1.280AUD
Spread / Average Target
+33.33%

Annual profits - Rate of surprise